Paroxetine Side Effects and Management

Introduction to Paroxetine Side Effects

The American Academy of Child and Adolescent Psychiatry notes that paroxetine has been specifically associated with increased risk of suicidal thinking or behavior compared to other SSRIs 1
The pooled absolute risk of suicidal thinking and behavior in patients through age 24 years is 1% for antidepressant-treated youth versus 0.2% for placebo, with a risk difference of 0.7% and number needed to harm of 143 2

The American Academy of Child and Adolescent Psychiatry recommends close monitoring of patients, especially during the first months of treatment and following dose adjustments, due to the risk of suicidal thinking and behavior 1, 2
Paroxetine is specifically noted as one of the SSRIs most strongly associated with discontinuation syndrome, which represents a critical prescribing consideration distinguishing paroxetine from other SSRIs 1
Behavioral activation or agitation can occur early in treatment or with dose increases, and is more common in younger children than adolescents, supporting slow up-titration and close monitoring 1
Mania or hypomania is a rare but serious side effect, typically appearing later in treatment, and may persist after SSRI discontinuation, requiring active pharmacological intervention 1, 2
Serotonin syndrome is a life-threatening condition caused by elevated brain serotonin levels, typically when paroxetine is combined with other serotonergic medications, and requires immediate hospitalization and discontinuation of all serotonergic agents 1, 2

The American Academy of Child and Adolescent Psychiatry notes that monoamine oxidase inhibitors (MAOIs) are absolutely contraindicated due to serotonin syndrome risk 1, 2
Other serotonergic drugs, including SNRIs, tricyclic antidepressants, atypical antidepressants, opioids, stimulants, dextromethorphan, and illicit drugs, require extreme caution when combined with paroxetine 1

The American Academy of Child and Adolescent Psychiatry recommends slow up-titration of paroxetine in children and adolescents to minimize behavioral activation and avoid exceeding optimal dose 1, 2
Parents, guardians, and patients should be educated in advance about potential side effects, particularly behavioral activation 1

Most side effects emerge within the first few weeks of treatment, and maximal therapeutic improvement typically occurs by week 12 or later, supporting gradual dose adjustments 2
The American Academy of Child and Adolescent Psychiatry notes that paroxetine has a greater margin of safety in overdose compared to tricyclic antidepressants, though deaths have been reported following very large ingestions 1